In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma
Abstract There are currently no effective treatments for advanced‐stage papillary renal cell carcinoma (PRCC). The goal of this study is to define potential DNA methylation‐based markers and treatment targets for advanced‐stage type 2 PRCC. Progressive DNA methylation changes and copy number variati...
Main Authors: | Man Yang, Ryan A. Hlady, Dan Zhou, Thai H. Ho, Keith D. Robertson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.2402 |
Similar Items
-
Initiation of aberrant DNA methylation patterns and heterogeneity in precancerous lesions of human hepatocellular cancer
by: Ryan A. Hlady, et al.
Published: (2017-03-01) -
DNA-Methylation Analysis as a Tool for Thymoma Classification
by: Timo Gaiser, et al.
Published: (2022-11-01) -
Mitochondrial DNA oxidation, methylation, and copy number alterations in major and bipolar depression
by: Deniz Ceylan, et al.
Published: (2023-12-01) -
DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results
by: Martinez-Pinteño A, et al.
Published: (2021-04-01) -
Exploring Differentially Methylated Genes in Vulvar Squamous Cell Carcinoma
by: Shatavisha Dasgupta, et al.
Published: (2021-07-01)